MKI67 and neoplasm: This system is based only on the proliferative activity of tumor cells, as measured by the number of mitotic cells confirmed per 10 high-power fields (HPFs) and/or by the percentage of tumor cells showing positive immunoreactivity for the Ki-67 antigen (the Ki-67 labeling index).